Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
8
×
investing
8
×
life sciences
national blog main
new york blog main
new york top stories
pfizer
8
×
san francisco blog main
san francisco top stories
startups
boston blog main
boulder/denver blog main
boulder/denver top stories
boston top stories
cancer immunotherapy
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
cancer
clinical trials
eli lilly
merck
amag pharmaceuticals
arch venture partners
What
bio
roundup
companies
develop
amid
bombast
cancer
caught
coronavirus
days
debate
discussion
drug
efforts
growing
led
life
meso’s
miss
pandemic
pfizer’s
pharmaceutical
presidential
promise
response
science
tuesday’s
typically
vaccine
viewers
alliance
alzheimer’s
approved
babies
bails
biotech
birth
boost
born
brand
Language
unset
Current search:
investing
×
pfizer
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More